Quantitative nuclear proteomics reveals new phenotypes altered in lymphoblastoid cells

Proteomics - Clinical Applications

Volumn 3, Issue 3, 2009, Pages 359-369

  Brennan, Paul ^a   Shore, Angharad M ^a   Clement, Mathew ^a   Hewamana, Saman ^a   Jones, Catrin M ^a   Giles, Peter ^a   Fegan, Christopher ^a   Pepper, Christopher ^a   Brewis, Ian A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

B cell; Coronin 1A; Epstein Barr virus; Transcription factor

Indexed keywords

NUCLEAR PROTEIN; PROTEOME; RIBONUCLEOPROTEIN;

ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL FRACTIONATION; CELL IMMORTALIZATION; CELL SIZE; CELL TYPE; CONTROLLED STUDY; CYTOSKELETON; EPSTEIN BARR VIRUS; FUNCTIONAL PROTEOMICS; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE ISOLATION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; LYMPHOBLASTOID CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA PROCESSING; TRANSCRIPTION REGULATION;

HUMAN HERPESVIRUS 4;

EID: 65549149212     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800137     Document Type: Article

References (36)

1. Rickinson, A. B., Kieff, E., in: Fields Virology, Fields, B. N., Knipe, D. M., Howley, P. M. (Eds.), Lippincott-Raven, Philadelphia 1996, pp. 2397-2446.
2. Unwin, R. D., Evans, C. A., Whetton, A. D., Relative quantification in proteomics: New approaches for biochemistry. Trends Biochem. Sci. 2006, 31, 473-484.
3. Brunet, S., Thibault, P., Gagnon, E., Kearney, P. et al., Organelle proteomics: Looking at less to see more. Trends Cell Biol. 2003, 13, 629-638.
4. Staudt, L. M., Dave, S., The biology of human lymphoid malignancies revealed by gene expression profiling. Adv. Immunol. 2005, 87, 163-208.
5. Brennan, P., Signalling events regulating lymphoid growth and survival. Semin. Cancer Biol. 2001, 11, 415-421.
6. Eliopoulos, A. G., Young, L. S., LMP1 structure and signal transduction. Semin. Cancer Biol. 2001, 11, 435-444.
7. Sinclair, A. J., Palmero, I., Peters, G., Farrell, P. J., EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 1994, 13, 3321-3328.
8. Zimber-Strobl, U., Strobl, L. J., EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin. Cancer Biol. 2001, 11, 423-434.
9. Takada, K., Nanbo, A., The role of EBERs in oncogenesis. Semin. Cancer Biol. 2001, 11, 461-467.
10. Rowe, M., Rooney, C. M., Edwards, C. F., Lenoir, G. M. et al., Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma. Int. J. Cancer 1986, 37, 367-373.
11. Brennan, P., O'Neill, L. A., Inhibition of nuclear factor kappaB by direct modification in whole cells - Mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem. Pharmacol. 1998, 55, 965-973.
12. Brennan, P., Mehl, A. M., Jones, M., Rowe, M., Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells. Oncogene 2002, 21, 1263-1271.
13. Rabilloud, T., Adessi, C., Giraudel, A., Lunardi, J., Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 1997, 18, 307-316.
14. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
15. Medzihradszky, K. F., Campbell, J. M., Baldwin, M. A., Falick, A. M. et al., The characteristics of peptide collision-induced dissociation using a high-performance MALDI-TOF/TOF tandem mass spectrometer. Anal. Chem. 2000, 72, 552-558.
16. Bienvenut, W. V., Deon, C., Pasquarello, C., Campbell, J. M. et al., Matrix-assisted laser desorption/ionization-tandem mass spectrometry with high resolution and sensitivity for identification and characterization of proteins. Proteomics 2002, 2, 868-876.
17. Gluckmann, M., Fella, K., Waidelich, D., Merkel, D. et al., Prevalidation of potential protein biomarkers in toxicology using iTRAQTM reagent technology. Proteomics 2007, 7, 1564-1574.
18. Perkins, D. N., Pappin, D. J., Creasy, D. M., Cottrell, J. S., Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20, 3551-3567.
19. Richardson, C., Fielding, C., Rowe, M., Brennan, P., Epstein-Barr virus regulates STAT1 through latent membrane protein 1. J. Virol. 2003, 77, 4439-4443.
20. Shore, A. M., White, P. C., Hui, R. C., Essafi, A. et al., Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A. J. Virol. 2006, 80, 11191-11199.
21. White, P. C., Shore, A. M., Clement, M., McLaren, J. et al., Regulation of cyclin D2 and the cyclin D2 promoter by protein kinase A and CREB in lymphocytes. Oncogene 2006, 25, 2170-2180.
22. Turner, H., Gomez, M., McKenzie, E., Kirchem, A. et al., Rac-1 regulates nuclear factor of activated T cells (NFAT) C1 nuclear translocation in response to Fcepsilon receptor type 1 stimulation of mast cells. J. Exp. Med. 1998, 188, 527-537.
23. Carmona-Saez, P., Chagoyen, M., Tirado, F., Carazo, J. M. et al., GENECODIS: A web-based tool for finding significant concurrent annotations in gene lists. Genome Biol. 2007, 8, R3.
24. Szekely, L., Pokrovskaja, K., Klein, G., Differential expression of nucleoskeleton-and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines. Cell Growth Differ. 1997, 8, 599-609.
25. Kaye, K. M., Izumi, K. M., Kieff, E., Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 1993, 90, 9150-9154.
26. Henrich, S., Crossett, B., Christopherson, R. I., Differentially expressed nuclear proteins in human CCRF-CEM, HL-60, MEC-1 and Raji cells correlate with cellular properties. Proteomics Clin. Appl. 2007, 1, 1252-1265.
27. Kukalev, A., Nord, Y., Palmberg, C., Bergman, T. et al., Actin and hnRNP U cooperate for productive transcription by RNA polymerase II. Nat. Struct. Mol. Biol. 2005, 12, 238-244.
28. Obrdlik, A., Kukalev, A., Percipalle, P., The function of actin in gene transcription. Histol. Histopathol. 2007, 22, 1051-1055.
29. Scaffidi, P., Misteli, T., Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat. Cell Biol. 2008, 10, 452-459.
30. Scaffidi, P., Misteli, T., Lamin A-dependent nuclear defects in human aging. Science 2006, 312, 1059-1063.
31. Foger, N., Rangell, L., Danilenko, D. M., Chan, A. C., Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis [see comment]. Science 2006, 313, 839-842.
32. Yanagisawa, Y., Sato, Y., Asahi-Ozaki, Y., Ito, E. et al., Effusion and solid lymphomas have distinctive gene and protein expression profiles in an animal model of primary effusion lymphoma. J. Pathol. 2006, 209, 464-473.
33. Mueller, P., Massner, J., Jayachandran, R., Combaluzier, B. et al., Regulation of Tcell survival through coronin-1-mediated generation of inositol-1,4,5-trisphosphate and calcium mobilization after T cell receptor triggering. Nat. Immunol. 2008, 9, 424-431.
34. Jin, T., Guo, F., Serebriiskii, I. G., Howard, A. et al., A 1.55 A resolution X-ray crystal structure of HEF2/ERH and insights into its transcriptional and cell-cycle interaction networks. Proteins 2007, 68, 427-437.
35. Wojcik, E., Murphy, A. M., Fares, H., Dang-Vu, K. et al., Enhancer of rudimentaryp1, e(r)p1, a highly conserved enhancer of the rudimentary gene. Genetics 1994, 138, 1163-1170.
36. Henrich, S., Cordwell, S. J., Crossett, B., Baker, M. S. et al., The nuclear proteome and DNA-binding fraction of human Raji lymphoma cells. Biochim. Biophys. Acta 2007, 1774, 413-432.